In this context, high PCT plasma concentrations were shown to be associated with higher mortality in critically ill patients [5], and recently PCT assessment in plasma from COVID-19 patients was demonstrated to provide prognostic information [6,7]. The gene discussed is CALCA; the disease is COVID-19.